Raziel Therapeutics scores $22 mln Series C
Raziel Therapeutics, a clinical-stage pharmaceutical company, has raised $22 million in Series C financing.
Raziel Therapeutics, a clinical-stage pharmaceutical company, has raised $22 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination